MeSH Review:

# Markov Chains

**Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Multicenter AIDS Cohort Study.**Graham, N.M., Zeger, S.L., Park, L.P., Phair, J.P., Detels, R., Vermund, S.H., Ho, M., Saah, A.J.*Lancet*(1991)**Significance testing of clinical data using virus dynamics models with a Markov chain Monte Carlo method: application to emergence of lamivudine-resistant hepatitis B virus.**Burroughs, N.J., Pillay, D., Mutimer, D.*Proc. Biol. Sci.*(1999)**A Markov chain model to assess the efficacy of screening for non-insulin dependent diabetes mellitus (NIDDM).**Kuo, H.S., Chang, H.J., Chou, P., Teng, L., Chen, T.H.*International journal of epidemiology.*(1999)**The molecular clock of HIV-1 unveiled through analysis of a known transmission history.**Leitner, T., Albert, J.*Proc. Natl. Acad. Sci. U.S.A.*(1999)**Application of Bayesian modeling of autologous antibody responses against ovarian tumor-associated antigens to cancer detection.**Erkanli, A., Taylor, D.D., Dean, D., Eksir, F., Egger, D., Geyer, J., Nelson, B.H., Stone, B., Fritsche, H.A., Roden, R.B.*Cancer Res.*(2006)**Sequential arrangement of gamma-valerolactone enantiomers enclathrated in cholic acid channels as studied by 13C solid-state NMR: elucidation of the optical resolution mechanism.**Nakamura, S., Imashiro, F., Takegoshi, K., Terao, T.*J. Am. Chem. Soc.*(2004)**The first, second, third and fourth order Markov chain analysis on the amino-acid sequence of human dopamine beta-hydroxylase.**Wu, G.*Mol. Psychiatry*(2000)**Interpersonal control and expressed emotion in families of persons with schizophrenia: change over time.**Wuerker, A.K., Haas, G.L., Bellack, A.S.*Schizophrenia bulletin.*(2001)**Quantification of DNA patchiness using long-range correlation measures.**Viswanathan, G.M., Buldyrev, S.V., Havlin, S., Stanley, H.E.*Biophys. J.*(1997)**A Bayesian approach to multipoint mapping in nuclear families.**Thomas, D.C., Richardson, S., Gauderman, J., Pitkäniemi, J.*Genet. Epidemiol.*(1997)**Bayesian estimation of variability in adipose tissue blood flow in man by physiologically based pharmacokinetic modeling of inhalation exposure to toluene.**Jonsson, F., Johanson, G.*Toxicology*(2001)**Characterization of endothelial cell locomotion using a Markov chain model.**Lee, Y., Markenscoff, P.A., McIntire, L.V., Zygourakis, K.*Biochem. Cell Biol.*(1995)**Communication patterns and expressed emotion in families of persons with mental disorders.**Wuerker, A.M.*Schizophrenia bulletin.*(1996)**Sources of plasma glucose by automated Bayesian analysis of 2H NMR spectra.**Merritt, M., Bretthorst, G.L., Burgess, S.C., Sherry, A.D., Malloy, C.R.*Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine.*(2003)**Bias explorer: measurements of compositional bias in EMBL and GenBank sequence files.**Fuglsang, A.*Antonie Van Leeuwenhoek*(2004)**The cost effectiveness of Helicobacter pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden.**Unge, P., Jönsson, B., Stålhammar, N.O.*PharmacoEconomics.*(1995)**Promoter strength prediction based on occurrence frequencies of consensus patterns.**Weller, K., Recknagel, R.D.*J. Theor. Biol.*(1994)**Cost-effectiveness of two follow-up strategies for curative resection of colorectal cancer: comparative study using a Markov model.**Borie, F., Combescure, C., Daurès, J.P., Trétarre, B., Millat, B.*World journal of surgery.*(2004)**Activation of N-methyl-D-aspartate receptors by L-glutamate in cells dissociated from adult rat hippocampus.**Gibb, A.J., Colquhoun, D.*J. Physiol. (Lond.)*(1992)**Efficacy of breast-cancer screening for female relatives of breast-cancer-index cases: Taiwan multicentre cancer screening (TAMCAS).**Lai, M.S., Yen, M.F., Kuo, H.S., Koong, S.L., Chen, T.H., Duffy, S.W.*Int. J. Cancer*(1998)**Evaluation of screening for nasopharyngeal carcinoma: trial design using Markov chain models.**Chen, H.H., Prevost, T.C., Duffy, S.W.*Br. J. Cancer*(1999)**Modeling the time course of CD4 T-lymphocyte counts according to the level of virologic rebound in HIV-1-infected patients on highly active antiretroviral therapy.**Kousignian, I., Abgrall, S., Duval, X., Descamps, D., Matheron, S., Costagliola, D.*J. Acquir. Immune Defic. Syndr.*(2003)